Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -8.46% is 837% below its 2-year average of -0.90%, around the middle of its 2-year range (-20.48%–11.17%).
8.07% above its 12-month average of -9.20%.
Reported quarterly profit margin; no daily interpolation. Q4 FY2026 (2026-03-31): -20.48%.
NET PROFIT MARGIN
-8.46%
NET PROFIT MARGIN AVG TTM
-9.20%
NET PROFIT MARGIN AVG 3Y
N/A
NET PROFIT MARGIN AVG 5Y
N/A
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+8.07%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.26%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-3153.85%
vs the sector median at left
Cellyan Biotechnology Co., Ltd
Market Cap
$1.13M
Net Profit Margin
-8.46%
TTM Avg
-9.20%
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.12M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.17M
Net Profit Margin
-38.08%
TTM Avg
-20.13%
3Y Avg
-101.84%
5Y Avg
-106.69%
Market Cap
$1.08M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.01M
Net Profit Margin
-11314.24%
TTM Avg
-197362.53%
3Y Avg
-98681.26%
5Y Avg
-78945.01%
Market Cap
$946332.00
Net Profit Margin
-16.50%
TTM Avg
-15.59%
3Y Avg
-166.33%
5Y Avg
-1668.08%
Market Cap
$1.34M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cellyan Biotechnology Co., Ltd (HKPD) | $1.13M | -8.46% | -9.20% | N/A | N/A |
| Propanc Biopharma, Inc. (PPCB)vs › | $1.12M | 0.00% | 0.00% | 0.00% | 0.00% |
| IM Cannabis Corp. (IMCC)vs › | $1.17M | -38.08% | -20.13% | -101.84% | -106.69% |
| Clearmind Medicine Inc. (CMND)vs › | $1.08M | 0.00% | 0.00% | 0.00% | 0.00% |
| Aspire Biopharma Holdings, Inc. (ASBP)vs › | $1.01M | -11314.24% | -197362.53% | -98681.26% | -78945.01% |
| Sunshine Biopharma, Inc. (SBFM)vs › | $946332.00 | -16.50% | -15.59% | -166.33% | -1668.08% |
| Genprex, Inc. (GNPX)vs › | $1.32M | 0.00% | 0.00% | 0.00% | 0.00% |
| NewcelX Ltd. (NCEL)vs › | $1.33M | 0.00% | 0.00% | 0.00% | 0.00% |
| Artelo Biosciences, Inc. (ARTL)vs › | $1.34M | 0.00% | 0.00% | 0.00% | 0.00% |
| GlucoTrack, Inc. (GCTK)vs › | $901902.00 | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Margin
-7.4%
Net Profit Margin
-8.5%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-03-31 | -20.48% |
| 2025-09-30 | 2.15% |
| 2025-03-31 | -9.28% |
| 2024-09-30 | 7.47% |
| 2024-03-31 | 11.17% |
| 2023-09-30 | 3.55% |
